182 related articles for article (PubMed ID: 27313697)
41. MR diffusion kurtosis imaging for cancer diagnosis: A meta-analysis of the diagnostic accuracy of quantitative kurtosis value and diffusion coefficient.
Shen L; Zhou G; Tang F; Lin Y; Zhou J; Lv P; Wang Y; Zong G; Zhao J
Clin Imaging; 2018; 52():44-56. PubMed ID: 29908349
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions.
Cao J; Xiao L; He B; Zhang G; Dong J; Wu Y; Xie H; Wang G; Lin X
Clin Radiol; 2017 Sep; 72(9):793.e1-793.e9. PubMed ID: 28545685
[TBL] [Abstract][Full Text] [Related]
44. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
Xu X; Wang P; Ma L; Shao Z; Zhang M
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
[TBL] [Abstract][Full Text] [Related]
45. Value of diffusion-weighted magnetic resonance images for discrimination of focal benign and malignant hepatic lesions: a meta-analysis.
Xia D; Jing J; Shen H; Wu J
J Magn Reson Imaging; 2010 Jul; 32(1):130-7. PubMed ID: 20578019
[TBL] [Abstract][Full Text] [Related]
46. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
[TBL] [Abstract][Full Text] [Related]
47. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses?
Wu LM; Xu JR; Hua J; Gu HY; Chen J; Haacke EM; Hu J
Magn Reson Imaging; 2013 Feb; 31(2):235-46. PubMed ID: 22902469
[TBL] [Abstract][Full Text] [Related]
48. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
[TBL] [Abstract][Full Text] [Related]
49. The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis.
Hu X; Liang Z; Zhang C; Wang G; Cai J; Wang P
Front Oncol; 2022; 12():840433. PubMed ID: 35223521
[TBL] [Abstract][Full Text] [Related]
50. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
51. Apparent diffusion coefficient value of diffusion-weighted imaging for differential diagnosis of ductal carcinoma in situ and infiltrating ductal carcinoma.
Ding JR; Wang DN; Pan JL
J Cancer Res Ther; 2016; 12(2):744-50. PubMed ID: 27461644
[TBL] [Abstract][Full Text] [Related]
52. Standard-b-Value Versus Low-b-Value Diffusion-Weighted Imaging in Hepatic Lesion Discrimination: A Meta-analysis.
Xiong H; Zeng YL
J Comput Assist Tomogr; 2016; 40(3):498-504. PubMed ID: 26938696
[TBL] [Abstract][Full Text] [Related]
53. The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis.
Zhang L; Min Z; Tang M; Chen S; Lei X; Zhang X
J Neurol Sci; 2017 Feb; 373():9-15. PubMed ID: 28131237
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.
Fujii S; Kakite S; Nishihara K; Kanasaki Y; Harada T; Kigawa J; Kaminou T; Ogawa T
J Magn Reson Imaging; 2008 Nov; 28(5):1149-56. PubMed ID: 18972356
[TBL] [Abstract][Full Text] [Related]
55. MR imaging in discriminating between benign and malignant paediatric ovarian masses: a systematic review.
van Nimwegen LWE; Mavinkurve-Groothuis AMC; de Krijger RR; Hulsker CCC; Goverde AJ; Zsiros J; Littooij AS
Eur Radiol; 2020 Feb; 30(2):1166-1181. PubMed ID: 31529256
[TBL] [Abstract][Full Text] [Related]
56. Comparison and Optimization of 3.0 T Breast Images Quality of Diffusion-Weighted Imaging with Multiple B-Values.
Han X; Li J; Wang X
Acad Radiol; 2017 Apr; 24(4):418-425. PubMed ID: 27955879
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of diffusion-weighted imaging in differentiating glioma recurrence from posttreatment-related changes: a meta-analysis.
Du X; He Q; Zhang B; Li N; Zeng X; Li W
Expert Rev Anticancer Ther; 2022 Jan; 22(1):123-130. PubMed ID: 34727815
[TBL] [Abstract][Full Text] [Related]
58. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
[TBL] [Abstract][Full Text] [Related]
59. Differential Diagnosis of Benign and Malignant Breast Tumors Using Apparent Diffusion Coefficient Value Measured Through Diffusion-Weighted Magnetic Resonance Imaging.
Qu RF; Guo DR; Chang ZX; Meng J; Sun Y; Hao SH; Shi G; Sun J
J Comput Assist Tomogr; 2015; 39(4):513-22. PubMed ID: 25783797
[TBL] [Abstract][Full Text] [Related]
60. Meta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses.
Niu XK; Bhetuwal A; Das S; Xiao YQ; Sun F; Zeng LC; Yang HF
J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):950-956. PubMed ID: 25480596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
